Wu, Yuanyuan <br/><br/>
Anacardic acid (6-pentadecylsalicylic acid) inhibits tumor angiogenesis by targeting Src/FAK/Rho GTPases signaling pathway.  [electronic resource] 

 -  The Journal of pharmacology and experimental therapeutics  Nov 2011 
 - 403-11 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1521-0103 
<br/><br/><label>Standard No.: </label>10.1124/jpet.111.181891  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anacardic Acids--pharmacology<br/>Angiogenesis Inhibitors--pharmacology<br/>Animals<br/>Cell Proliferation--drug effects<br/>Chick Embryo<br/>Chorioallantoic Membrane--drug effects<br/>Corneal Neovascularization--drug therapy<br/>Dose-Response Relationship, Drug<br/>Focal Adhesion Kinase 1--metabolism<br/>GTP Phosphohydrolases--metabolism<br/>Human Umbilical Vein Endothelial Cells<br/>Humans<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Molecular Targeted Therapy<br/>Neovascularization, Pathologic--drug therapy<br/>Prostatic Neoplasms--blood supply<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Signal Transduction--drug effects<br/>Time Factors<br/>Vascular Endothelial Growth Factor Receptor-2--antagonists & inhibitors<br/>Xenograft Model Antitumor Assays<br/>rho GTP-Binding Proteins--agonists<br/>rho-Associated Kinases--metabolism<br/>src-Family Kinases--metabolism